SAB Biotherapeutics, Inc.
SABS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5 | -$10 | -$5 | -$11 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $1 | $0 |
| Change in WC | $2 | $1 | $1 | -$2 |
| Other Non-Cash | -$21 | $1 | -$5 | $3 |
| Operating Cash Flow | -$13 | -$7 | -$8 | -$9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$130 | -$0 | -$0 | -$1 |
| Inv. Sales/Matur. | $0 | $5 | $5 | $11 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$130 | $5 | $5 | $9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $169 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | -$0 | -$0 |
| Financing Cash Flow | $169 | -$0 | -$0 | -$0 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $26 | -$2 | -$3 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $6 | $9 | $9 |
| End Cash | $29 | $4 | $6 | $9 |
| Free Cash Flow | -$13 | -$7 | -$8 | -$9 |